121 – 130 of 164
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1995
-
Mark
Fluorescence Diagnostics of Head and Neck Cancer Utilizing Oral Administration of Delta-amino Levulinic Acid
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Pharmacokinetic studies of delta-amino levulinic acid-induced protoporphyrin IX build-up in some malignant tumours
1995) Conference on Advances in Laser and Light Spectroscopy to Diagnose Cancer and Other Diseases II, SAN JOSE, CA, FEB 07-08, 1995 2387. p.30-42(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Photodynamic Therapy of Non-melanoma Skin Malignancies with Topical Delta-amino Levulinic Acid - Diagnostic Measurements
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Clinical detection studies of Barrett's metaplasia and oesophageal adenocarcinoma by means of laser-induced fluorescence
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Optical detection of human urinary bladder carcinoma utilising tissue autofluorescence and protoporphyrin IX-induced fluorescence following low-dose ALA instillation
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Multi-colour fluorescence imaging in connection with photodynamic therapy of delta-amino levulinic acid (ALA) sensitised skin malignancies
(
- Contribution to journal › Article
- 1994
-
Mark
Laser-induced Fluorescence Studies of Meso-tetra(hydroxyphenyl)chlorin In Malignant and Normal-tissues In Rats
(
- Contribution to journal › Article
-
Mark
Laser-induced Ala Photodynamic Therapy In the Treatment of Rat-liver Tumor
(
- Contribution to journal › Article
-
Mark
Photodynamic Therapy of Nonmelanoma Malignant-tumors of the Skin Using Topical Delta-amino Levulinic Acid Sensitization and Laser Irradiation
(
- Contribution to journal › Article
-
Mark
Beneficial-effects of Platelet-activating-factor Receptor Antagonist Web-2170 On 90-minute Hepatic Inflow Interruption
(
- Contribution to journal › Article